These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 24719318)

  • 1. Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1.
    Bao B; Azmi AS; Aboukameel A; Ahmad A; Bolling-Fischer A; Sethi S; Ali S; Li Y; Kong D; Banerjee S; Back J; Sarkar FH
    J Biol Chem; 2014 May; 289(21):14520-33. PubMed ID: 24719318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentially expressed miRNAs in cancer-stem-like cells: markers for tumor cell aggressiveness of pancreatic cancer.
    Bao B; Ali S; Ahmad A; Li Y; Banerjee S; Kong D; Aboukameel A; Mohammad R; Van Buren E; Azmi AS; Sarkar FH
    Stem Cells Dev; 2014 Aug; 23(16):1947-58. PubMed ID: 24734907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the K-Ras--JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formation.
    Okada M; Shibuya K; Sato A; Seino S; Suzuki S; Seino M; Kitanaka C
    Oncotarget; 2014 Jul; 5(13):5100-12. PubMed ID: 24947996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells.
    Xue ZX; Zheng JH; Zheng ZQ; Cai JL; Ye XH; Wang C; Sun WJ; Zhou X; Lu MD; Li PH; Cai ZZ
    World J Surg Oncol; 2014 Dec; 12():404. PubMed ID: 25551472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
    Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
    Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
    Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
    PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells.
    Bao B; Wang Z; Ali S; Kong D; Li Y; Ahmad A; Banerjee S; Azmi AS; Miele L; Sarkar FH
    Cancer Lett; 2011 Aug; 307(1):26-36. PubMed ID: 21463919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
    Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
    J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
    Chen KL; Pan F; Jiang H; Chen JF; Pei L; Xie FW; Liang HJ
    Clin Exp Metastasis; 2011 Dec; 28(8):751-63. PubMed ID: 21750907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer.
    Bao B; Ali S; Kong D; Sarkar SH; Wang Z; Banerjee S; Aboukameel A; Padhye S; Philip PA; Sarkar FH
    PLoS One; 2011 Mar; 6(3):e17850. PubMed ID: 21408027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
    Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
    Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
    PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells.
    Chen Y; Yu D; Zhang H; He H; Zhang C; Zhao W; Shao RG
    Int J Biol Sci; 2012; 8(7):992-1004. PubMed ID: 22904667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An epithelial cell adhesion molecule- and CD3-bispecific antibody plus activated T-cells can eradicate chemoresistant cancer stem-like pancreatic carcinoma cells in vitro.
    Umebayashi M; Kiyota A; Koya N; Tanaka H; Onishi H; Katano M; Morisaki T
    Anticancer Res; 2014 Aug; 34(8):4509-19. PubMed ID: 25075094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.
    Palagani V; El Khatib M; Kossatz U; Bozko P; Müller MR; Manns MP; Krech T; Malek NP; Plentz RR
    PLoS One; 2012; 7(10):e46514. PubMed ID: 23094026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
    Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z
    Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis.
    Nallasamy P; Nimmakayala RK; Karmakar S; Leon F; Seshacharyulu P; Lakshmanan I; Rachagani S; Mallya K; Zhang C; Ly QP; Myers MS; Josh L; Grabow CE; Gautam SK; Kumar S; Lele SM; Jain M; Batra SK; Ponnusamy MP
    Gastroenterology; 2021 Dec; 161(6):1998-2013.e7. PubMed ID: 34418441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer.
    Xiang T; Long H; He L; Han X; Lin K; Liang Z; Zhuo W; Xie R; Zhu B
    Oncogene; 2015 Jan; 34(2):165-76. PubMed ID: 24362529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.